Table 5.
30-Day Morbidity |
||
---|---|---|
Patient Characteristics | Adjusted OR (95% CI) | P Value |
Sex | .09 | |
Male | Reference | |
Female | 1.58 (0.97-2.59) | |
Race | .54 | |
White | Reference | |
African American | 1.43 (0.83-2.49) | |
Others | 1.18 (0.26-5.45) | |
BMI | 0.94 (0.91-0.98) | .003a |
ASA status | 2.05 (1.14-3.68) | .0l5a |
Primary site | .16 | |
Oropharynx | Reference | |
Larynx | 1.18 (0.63-2.21) | |
Hypopharynx | 0.67 (0.22-2.11) | |
Oral cavity | 1.32 (0.74-2.34) | |
Others | 0.39 (0.15-1.07) | |
AJCC stage | .l7 | |
1 | Reference | |
2 | 1.51 (0.71-3.24) | |
3 | 1.44 (0.71-2.92) | |
4A | 1.68 (0.9-3.11) | |
4B | 1.35 (0.51-3.6) | |
Unknown | 0.34 (0.08-1.42) | |
SAS | <.0001a | |
1-4 | Reference | |
5-6 | 0.44 (0.22-0.88) | |
7-8 | 0.15 (0.07-0.33) | |
9-10 | 0.11 (0.03-0.47) |
Abbreviations: AJCC, American Joint Committee on Cancer; ASA, American Society of Anesthesiologists; BMI, body mass index; SAS, surgical Apgar score.
Denotes statistical significance at P < .05.